KANDESS ANDERSON: Open Payments
NPI 1275764755 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 145 payments from 22 companies in 2025. Trend: 2023 $1,396 · 2024 $1,870 · 2025 $2,416
Food & beverage: $2,416
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $264 |
| Novo Nordisk Inc | 18 | $260 |
| PFIZER INC. | 14 | $224 |
| Astellas Pharma US Inc | 14 | $209 |
| ABBVIE INC. | 12 | $189 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| Lilly USA, LLC | 6 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $123 |
| Phathom Pharmaceuticals, Inc. | 11 | $121 |
| Lundbeck LLC | 5 | $103 |
Products named: REXULTI, Veozah, Wegovy, AIRSUPRA, NURTEC ODT, TRINTELLIX, VOQUEZNA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
